FDA Inspection 1156170 — Bespak HC Limited

Bespak HC Limited — FEI 3001621739

The FDA completed an inspection of Bespak HC Limited on November 26, 2020 in Crewe. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 26, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Crewe (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)